Network

International

 

DAAD

  • Pagel / University of Namibia, Namibia Breathe (2018-2021)

 

Europe

Horizon 2020

  • anTBiotic (2017-2021): Entwicklung von Antibiotika für die Therapie der Tuberklose und neuer Ansätze für die individualisierte Therapie. Partner: Leibniz-Klinik Borstel (Prof. C. Lange), GlaxoSmithKline, Tres Cantos (Spanien), Universitäten von Cape Town und Stellenbosch, Südafrika und Universität von Tromsö, Norwegen.
  • CARE (2019-2020): Common Action against HIV/TB/HCV across the regions of Europe
  • ClicTB (2019- ): ClicTB (2019 - ): The purpose of Clic-TB is the identification and validation of new combination TB drug regimen consisting of one or more novel development candidates for progression to definitive late stage trials. Borstel will further validate biomarkers (urine trDNA, transcriptomics) as novel read-outs for the early bactericidal activity, which will also involve PET-CT scans of affected patients in South Africa.
  • WANETAM: Das Westafrika-NoE für TB, AIDS und Malaria (WANETAM) baut Kapazitäten auf, um westafrikanische Standorte für klinische Studien zu HIV, TB und Malaria vorzubereiten. Das Netzwerk hat seine Tätigkeit am 31. Juli 2009 aufgenommen.
  • FLAV4AMR (2019- ): Flavodoxin inhibitors to kill resistant bacteria

European Centre für Disease Prevention and Control (ECDPC)

  • ElseqMyTB (2017- )

 

 Welcome Trust / B & M Gates Foundation

  • CRyPTIC - Comprehensive Resistance Prediction for Tuberculosis: an International Consortium

 

United States Agency for International Development (USAID)

  • Stop TTH (2017 - )

 

Further Cooperations:

  • University of Xiamen: Establishment of the Xiamen-Borstel Joint Laboratory of Autoimmunity at the Medical College of Xiamen University under the leadership of Prof. Xinhua Yu
  • University of Namibia: Establishment of a tuberculosis research laboratory and a training curriculum on infectious diseases. Co-financed by the Schleswig-Holsteinische TB-Gesellschaft.